Category: Finance
-
Start-Up to Engineer T-Cells for Autoimmune Diseases
GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases.
-
Venture Fund Plans $350M for Biotech Start-Ups
A new venture fund plans investments in early-stage life science companies addressing critical needs in therapeutics, but also agriculture and industrial biotechnology.
-
New Allergy Biotech Launches, Raises $10M
A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is raising $10 million in its first venture funding round.
-
NIH Issues Contracts for Faster Covid-19 Diagnostics
National Institutes of Health awarded contracts to seven companies for higher-speed Covid-19 detection tests to ease current reporting delays.
-
Neuro Disease Start-Up Raises $73M in Early Funds
A company developing new therapies for neurodegenerative diseases officially began operations, staked to $73 million raised in its first venture round.
-
Synthetic Protein Maker Raises $91.3M in Venture Funds
A company creating animal-free designer proteins for skin care products is raising more than $91 million in its second venture funding round.
-
Venture Funding Down in 2020, Life Sciences Stay Hot
For the first half of 2020, venture investing declined compared to 2019, but life science and biotechnology investments continued growing for the year.
-
NIH Expands Covid-19 Test Technology Challenge
National Institutes of Health is expanding its challenge competition to make tests for Covid-19 viruses more widely available and return results faster.
-
Start-Up Developing Inside-Cell Delivery, Gains $28.5M
A new company spun-off from Harvard University is developing techniques for delivering advanced genetic and protein therapies directly inside cells.
-
Gene Therapy Production Company Opens, Raises $40M
A new enterprise developing and manufacturing gene therapies, both its own and for others, is underway, raising $40 million in venture funds.